Question of the Day – Monday August 14, 2017
Question: In patients taking injectable insulin, what is the suspected avcse for insulin-mediated lipohypertrophy?
Question of the Day – Wednesday August 9, 2017
Question: Which opioid, developed for veterinary use, is 10,000 times more potent than morphine, yet induces less apnea when given in therapeutically doses.
Question of the Day – Tuesday August 8, 2017
Question: Latrodectus mactans (black widow spider) envenomation has been reported to cause priapism in some patients. What is the most effective treatment for this form of priapism?
Question of the Day – Monday August 7, 2017
Question: Fentanyl administered by intravenous bolus can be associated with cough that may, at times, be severe. What are the risk factors for the development of fentanyl-induced cough?
Question of the Day – Friday August 4, 2017
Question: Ciguatera is caused by eating reef fish that contain toxins known as ciguatoxins. Which specific parts of these fish contain the highest concentrations of ciguatoxins?
Question of the Day – Thursday August 3, 2017
Question: A 54-year-old male worker presents with scleroderma-like changes in the fingers with underlying erosive appearing lesions of the distal most phalanges on x-ray. In addition, the patient describes circulatory changes consistent with Raynaud’s phenomena. This clinical picture is consistent with occupational exposure to which industrial chemical.
Question of the Day – Wednesday August 2, 2017
Question: What is the so-called “fentanyl footprint”?
Question of the Day – Tuesday August 1, 2017
Question: What is the immediate treatment for malignant hyperthermia crisis?